{"title":"Approaches to optimize analyses of multidimensional ordinal MRI data in osteoarthritis research: A perspective","authors":"Jamie E. Collins , Frank W. Roemer , Ali Guermazi","doi":"10.1016/j.ocarto.2024.100465","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><p>Knee osteoarthritis (OA) is a disease of the whole joint involving multiple tissue types. MRI-based semi-quantitative (SQ) scoring of knee OA is a method to perform multi-tissue joint assessment and has been shown to be a valid and reliable way to measure structural multi-tissue involvement and progression of the disease. While recent work has described how SQ scoring may be used for clinical trial enrichment and disease phenotyping in OA, less guidance is available for how these parameters may be used to assess study outcomes.</p></div><div><h3>Design</h3><p>Here we present recommendations for summarizing disease progression within specific tissue types. We illustrate how various methods may be used to quantify longitudinal change using SQ scoring and review examples from the literature.</p></div><div><h3>Results</h3><p>Approaches to quantify longitudinal change across subregions include the count of number of subregions, delta-subregion, delta-sum, and maximum grade changes. Careful attention should be paid to features that may fluctuate, such as bone marrow lesions, or with certain interventions, for example pharmacologic interventions with anticipated cartilage anabolic effects. The statistical approach must align with the nature of the outcome.</p></div><div><h3>Conclusions</h3><p>SQ scoring presents a way to understand disease progression across the whole joint. As OA is increasingly recognized as a heterogeneous disease with different phenotypes a better understanding of longitudinal progression across tissue types may present an opportunity to match study outcome to patient phenotype or to treatment mechanism of action.</p></div>","PeriodicalId":74377,"journal":{"name":"Osteoarthritis and cartilage open","volume":"6 2","pages":"Article 100465"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2665913124000323/pdfft?md5=d48f2f35d43a8d2429f6118623bd755d&pid=1-s2.0-S2665913124000323-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Osteoarthritis and cartilage open","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2665913124000323","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Objective
Knee osteoarthritis (OA) is a disease of the whole joint involving multiple tissue types. MRI-based semi-quantitative (SQ) scoring of knee OA is a method to perform multi-tissue joint assessment and has been shown to be a valid and reliable way to measure structural multi-tissue involvement and progression of the disease. While recent work has described how SQ scoring may be used for clinical trial enrichment and disease phenotyping in OA, less guidance is available for how these parameters may be used to assess study outcomes.
Design
Here we present recommendations for summarizing disease progression within specific tissue types. We illustrate how various methods may be used to quantify longitudinal change using SQ scoring and review examples from the literature.
Results
Approaches to quantify longitudinal change across subregions include the count of number of subregions, delta-subregion, delta-sum, and maximum grade changes. Careful attention should be paid to features that may fluctuate, such as bone marrow lesions, or with certain interventions, for example pharmacologic interventions with anticipated cartilage anabolic effects. The statistical approach must align with the nature of the outcome.
Conclusions
SQ scoring presents a way to understand disease progression across the whole joint. As OA is increasingly recognized as a heterogeneous disease with different phenotypes a better understanding of longitudinal progression across tissue types may present an opportunity to match study outcome to patient phenotype or to treatment mechanism of action.
目的 膝关节骨关节炎(OA)是一种涉及多种组织类型的全关节疾病。基于核磁共振成像的膝关节 OA 半定量(SQ)评分是一种进行多组织关节评估的方法,已被证明是测量多组织结构受累和疾病进展的一种有效而可靠的方法。虽然最近的研究已经描述了如何将SQ评分用于OA的临床试验富集和疾病表型,但对于如何将这些参数用于评估研究结果却缺乏指导。结果量化亚区域纵向变化的方法包括亚区域数量计数、delta-亚区域、delta-总和和最大等级变化。应仔细关注可能会波动的特征,如骨髓病变,或某些干预措施,如药物干预,预期会产生软骨同化效应。结论SQ评分是了解整个关节疾病进展的一种方法。由于人们越来越认识到 OA 是一种具有不同表型的异质性疾病,因此更好地了解不同组织类型的纵向进展可能会为将研究结果与患者表型或治疗作用机制相匹配提供机会。